S

StemRIM Inc
TSE:4599

Watchlist Manager
StemRIM Inc
TSE:4599
Watchlist
Price: 305 JPY
Market Cap: 18.9B JPY
Have any thoughts about
StemRIM Inc?
Write Note

StemRIM Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

StemRIM Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
S
StemRIM Inc
TSE:4599
Operating Expenses
-ÂĄ2.1B
CAGR 3-Years
-1%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Operating Expenses
-ÂĄ9.3B
CAGR 3-Years
-4%
CAGR 5-Years
-15%
CAGR 10-Years
-28%
PeptiDream Inc
TSE:4587
Operating Expenses
-ÂĄ11B
CAGR 3-Years
-39%
CAGR 5-Years
-40%
CAGR 10-Years
-43%
Takara Bio Inc
TSE:4974
Operating Expenses
-ÂĄ24B
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-8%
Pharma Foods International Co Ltd
TSE:2929
Operating Expenses
-ÂĄ42.8B
CAGR 3-Years
-7%
CAGR 5-Years
-38%
CAGR 10-Years
-44%
C
Cuorips Inc
TSE:4894
Operating Expenses
-ÂĄ598.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

StemRIM Inc
Glance View

Market Cap
18.8B JPY
Industry
Biotechnology

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 46 full-time employees. The company went IPO on 2019-08-09. The firm is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.

Intrinsic Value
150.01 JPY
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is StemRIM Inc's Operating Expenses?
Operating Expenses
-2.1B JPY

Based on the financial report for Jul 31, 2024, StemRIM Inc's Operating Expenses amounts to -2.1B JPY.

What is StemRIM Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-20%

Over the last year, the Operating Expenses growth was 6%. The average annual Operating Expenses growth rates for StemRIM Inc have been -1% over the past three years , -20% over the past five years .

Back to Top